Phenotypic modulation of mesenteric vascular smooth muscle cells from type 2 diabetic rats is associated with

Maria Alicia Carrillo-Sepulveda1, Takayuki Matsumoto

  • 1Department of Physiology, Georgia Regents University, Augusta, GA, USA.

Abstract

Insights

Diabetic mesenteric vascular smooth muscle cells (VSMCs) show reduced caveolin-1, promoting a proliferative phenotype. This vascular smooth muscle cell modulation is linked to increased inflammation and glucose levels in diabetes.

Area of Science:

  • Vascular Biology
  • Cellular Metabolism
  • Diabetes Complications

Background:

  • Vascular smooth muscle cell (VSMC) phenotypic modulation contributes to diabetes-associated vascular complications.
  • Loss of caveolin-1 expression is implicated in VSMC proliferation.

Purpose of the Study:

  • To investigate if mesenteric VSMCs from type 2 diabetic Goto-Kakizaki (GK) rats exhibit phenotypic modulation linked to decreased caveolin-1 expression.
  • To explore the role of inflammatory stimuli and glucose in these diabetic vascular changes.

Main Methods:

  • Isolated mesenteric VSMCs from GK and Wistar rats.
  • Western blotting for caveolin-1, calponin, and PCNA.
  • Assessed reactive oxygen species (ROS) and ERK1/2 activation.

Main Results:

  • Diabetic GK rat VSMCs showed reduced caveolin-1 and calponin, increased PCNA, elevated ROS, and phospho-ERK1/2.
  • LPS and high glucose exacerbated these changes in VSMCs.

Conclusions:

  • Mesenteric VSMCs in diabetic GK rats undergo phenotypic modulation associated with decreased caveolin-1.
  • Enhanced inflammation and glucose levels likely drive these diabetic vascular alterations.

Related Concept Videos

Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
8
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
6
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
5